Current Pharmacogenomics and Personalized Medicine
Title: Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology)
Volume: 9 Issue: 3
Author(s): Panga Jaipal Reddy, Rekha Jain, Young-Ki Paik, Robin Downey, Adam S. Ptolemy, Vural Ozdemir and Sanjeeva Srivastava
Affiliation:
Keywords: Human Proteome Project, India, knowledge-based innovation, personalized medicine, pharmacoproteomics, protein microarrays, South Asia and diagnostic medicine, upstream technology assessment
Export Options
About this article
Cite this article as:
Jaipal Reddy Panga, Jain Rekha, Paik Young-Ki, Downey Robin, S. Ptolemy Adam, Ozdemir Vural and Srivastava Sanjeeva, Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology), Current Pharmacogenomics and Personalized Medicine 2011; 9 (3) . https://dx.doi.org/10.2174/187569211796957557
DOI https://dx.doi.org/10.2174/187569211796957557 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radioactive Nanoparticles and their Main Applications: Recent Advances
Recent Patents on Nanotechnology The Long and Winding Road to Cancer Treatment: The Trail System
Current Pharmaceutical Design The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Upregulation of DLX2 Confers a Poor Prognosis in Glioblastoma Patients by Inducing a Proliferative Phenotype
Current Molecular Medicine Glioma Therapy: A Novel Insight in the Immunotherapeutic Regime with T11TS/SLFA-3
Central Nervous System Agents in Medicinal Chemistry Non-Cytotoxic Radiosensitizers in Brain Radiotherapy: Journey Till the First Decade of this Millennium
Current Cancer Drug Targets Tracking the Mesenchymal Stem Cell Fate After Transplantation Into the Infarcted Myocardium
Current Stem Cell Research & Therapy Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era
Anti-Cancer Agents in Medicinal Chemistry Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
Current Neuropharmacology Targeted Therapies in Gynecologic Cancers
Current Cancer Drug Targets Positron Emitting Tracers in Pre-Clinical Drug Development
Current Radiopharmaceuticals Stimuli-Responsive Nanoparticles for siRNA Delivery
Current Pharmaceutical Design The Role of Shcbp1 in Signaling and Disease
Current Cancer Drug Targets Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Current Cancer Therapy Reviews Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Current Cancer Drug Targets Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Current Cancer Drug Targets Chemical Consequences of Radioactive Decay and their Biological Implications
Current Radiopharmaceuticals Arsenic Trioxide and Artemisinin Act Synergistically to Kill Tumor Cells In Vitro
Anti-Cancer Agents in Medicinal Chemistry A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry